Journal article
AUSTRALIAN MULTICENTRE TRIAL OF STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTION
Abstract
In a multicentre controlled trial 517 patients with the clinical diagnosis of myocardial infarction within the preceding 24 hours were admitted to coronary-care units, and allocated at random to receive streptokinase followed by heparin and warfarin (264 patients) or anticoagulants only (253 patients). On retrospective analysis the groups were found to be comparable. 26 (9·8%) of those treated with streptokinase and 32 (12·6%) of those in the …
Authors
Bett JHN; Castaldi PA; Hale GS; Isbister JP; Mclean KH; O'Sullivan EF; Biggs JC; Chesterman CN; Hirsh J; Mcdonald IG
Journal
The Lancet, Vol. 301, No. 7794, pp. 57–60
Publisher
Elsevier
Publication Date
1 1973
DOI
10.1016/s0140-6736(73)90463-7
ISSN
0140-6736